{"entity":{"type":"insider","cik":"0001376260","url":"/insider/0001376260","json_url":"/insider/0001376260.json","name":"LOWE CHRISTOPHER P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":25,"n_filings":14,"first":"2010-04-30","last":"2022-08-26","span_basis":"filed_date"},"name_variants":[{"name":"LOWE CHRISTOPHER P.","source":"filing","n_filings":14,"first_seen":"2010-04-30","last_seen":"2022-08-26"}],"transactions":[{"id":6264284,"accession":"0000899243-22-029840","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-029840","line_url":"/filing/0000899243-22-029840#line-2","is_derivative":false,"issuer_cik":"0001376260","issuer_name":"Vincerx Pharma, Inc.","issuer_ticker":"VINC","issuer_name_source":null,"issuer_url":"/issuer/0001376260","owner_cik":"0001376260","owner_name":"LOWE CHRISTOPHER P.","owner_display_name":"LOWE CHRISTOPHER P.","owner_url":"/insider/0001376260","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11600.0,"shares_display":"11,600","price_per_share":1.6499,"price_display":"1.65","price_state":"stated","total_value":19138.84,"total_display":"19,138.84","total_whole":"19,139","shares_owned_after":40000.0,"shares_owned_after_display":"40,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-25","filed_date":"2022-08-26","scope":"insider"},{"id":6264282,"accession":"0000899243-22-029840","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-029840","line_url":"/filing/0000899243-22-029840#line-1","is_derivative":false,"issuer_cik":"0001376260","issuer_name":"Vincerx Pharma, Inc.","issuer_ticker":"VINC","issuer_name_source":null,"issuer_url":"/issuer/0001376260","owner_cik":"0001376260","owner_name":"LOWE CHRISTOPHER P.","owner_display_name":"LOWE CHRISTOPHER P.","owner_url":"/insider/0001376260","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":18400.0,"shares_display":"18,400","price_per_share":1.6467,"price_display":"1.65","price_state":"stated","total_value":30299.28,"total_display":"30,299.28","total_whole":"30,299","shares_owned_after":28400.0,"shares_owned_after_display":"28,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-24","filed_date":"2022-08-26","scope":"insider"},{"id":4540215,"accession":"0001209191-21-059984","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-059984","line_url":"/filing/0001209191-21-059984#line-2","is_derivative":false,"issuer_cik":"0001376260","issuer_name":"Cortexyme, Inc.","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001376260","owner_cik":"0001376260","owner_name":"LOWE CHRISTOPHER P.","owner_display_name":"LOWE CHRISTOPHER P.","owner_url":"/insider/0001376260","role":"Officer (COO & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (COO & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4963.0,"shares_display":"4,963","price_per_share":98.5,"price_display":"98.50","price_state":"stated","total_value":488855.5,"total_display":"488,855.50","total_whole":"488,856","shares_owned_after":60000.0,"shares_owned_after_display":"60,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-05","filed_date":"2021-10-07","scope":"insider"},{"id":5477890,"accession":"0001209191-21-052277","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-21-052277","line_url":"/filing/0001209191-21-052277","is_derivative":false,"issuer_cik":"0001376260","issuer_name":"Cortexyme, Inc.","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001376260","owner_cik":"0001376260","owner_name":"LOWE CHRISTOPHER P.","owner_display_name":"LOWE CHRISTOPHER P.","owner_url":"/insider/0001376260","role":"Officer (COO & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (COO & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22000.0,"shares_display":"22,000","price_per_share":95.30813363636364,"price_display":"95.31","price_state":"stated","total_value":2096778.94,"total_display":"2,096,778.94","total_whole":"2,096,779","shares_owned_after":42842.0,"shares_owned_after_display":"42,842","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-16","filed_date":"2021-08-18","scope":"insider","n_lines":5},{"id":5031191,"accession":"0000899243-21-026816","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-026816","line_url":"/filing/0000899243-21-026816#line-2","is_derivative":false,"issuer_cik":"0001376260","issuer_name":"Vincerx Pharma, Inc.","issuer_ticker":"VINC","issuer_name_source":null,"issuer_url":"/issuer/0001376260","owner_cik":"0001376260","owner_name":"LOWE CHRISTOPHER P.","owner_display_name":"LOWE CHRISTOPHER P.","owner_url":"/insider/0001376260","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3600.0,"shares_display":"3,600","price_per_share":12.66,"price_display":"12.66","price_state":"stated","total_value":45576.0,"total_display":"45,576.00","total_whole":"45,576","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-30","filed_date":"2021-06-30","scope":"insider"},{"id":5031181,"accession":"0000899243-21-026816","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-026816","line_url":"/filing/0000899243-21-026816#line-1","is_derivative":false,"issuer_cik":"0001376260","issuer_name":"Vincerx Pharma, Inc.","issuer_ticker":"VINC","issuer_name_source":null,"issuer_url":"/issuer/0001376260","owner_cik":"0001376260","owner_name":"LOWE CHRISTOPHER P.","owner_display_name":"LOWE CHRISTOPHER P.","owner_url":"/insider/0001376260","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6400.0,"shares_display":"6,400","price_per_share":12.59,"price_display":"12.59","price_state":"stated","total_value":80576.0,"total_display":"80,576.00","total_whole":"80,576","shares_owned_after":6400.0,"shares_owned_after_display":"6,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-29","filed_date":"2021-06-30","scope":"insider"},{"id":5101592,"accession":"0001209191-21-044027","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-044027","line_url":"/filing/0001209191-21-044027","is_derivative":false,"issuer_cik":"0001376260","issuer_name":"Cortexyme, Inc.","issuer_ticker":"CRTX","issuer_name_source":null,"issuer_url":"/issuer/0001376260","owner_cik":"0001376260","owner_name":"LOWE CHRISTOPHER P.","owner_display_name":"LOWE CHRISTOPHER P.","owner_url":"/insider/0001376260","role":"Officer (COO & Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (COO & Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"COO & Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":54.153675,"price_display":"54.15","price_state":"stated","total_value":1083073.5,"total_display":"1,083,073.50","total_whole":"1,083,074","shares_owned_after":12276.0,"shares_owned_after_display":"12,276","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-28","filed_date":"2021-06-30","scope":"insider","n_lines":4},{"id":6672917,"accession":"0001181431-14-020496","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-020496","line_url":"/filing/0001181431-14-020496#line-1","is_derivative":false,"issuer_cik":"0001276591","issuer_name":"HANSEN MEDICAL INC","issuer_ticker":"HNSN","issuer_name_source":null,"issuer_url":"/issuer/0001276591","owner_cik":"0001376260","owner_name":"LOWE CHRISTOPHER P.","owner_display_name":"LOWE CHRISTOPHER P.","owner_url":"/insider/0001376260","role":"Director, Officer (Interim CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Interim CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":1.4445,"price_display":"1.44","price_state":"stated","total_value":28890.0,"total_display":"28,890.00","total_whole":"28,890","shares_owned_after":42500.0,"shares_owned_after_display":"42,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-20","filed_date":"2014-05-20","scope":"insider"},{"id":4736319,"accession":"0001181431-13-027957","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-027957","line_url":"/filing/0001181431-13-027957#line-1","is_derivative":false,"issuer_cik":"0001276591","issuer_name":"HANSEN MEDICAL INC","issuer_ticker":"HNSN","issuer_name_source":null,"issuer_url":"/issuer/0001276591","owner_cik":"0001376260","owner_name":"LOWE CHRISTOPHER P.","owner_display_name":"LOWE CHRISTOPHER P.","owner_url":"/insider/0001376260","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12500.0,"shares_display":"12,500","price_per_share":1.52,"price_display":"1.52","price_state":"stated","total_value":19000.0,"total_display":"19,000.00","total_whole":"19,000","shares_owned_after":22500.0,"shares_owned_after_display":"22,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-13","filed_date":"2013-05-15","scope":"insider"},{"id":3278278,"accession":"0001104659-12-006560","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-12-006560","line_url":"/filing/0001104659-12-006560#line-1","is_derivative":false,"issuer_cik":"0001316175","issuer_name":"Anthera Pharmaceuticals Inc","issuer_ticker":"ANTH","issuer_name_source":null,"issuer_url":"/issuer/0001316175","owner_cik":"0001376260","owner_name":"LOWE CHRISTOPHER P.","owner_display_name":"LOWE CHRISTOPHER P.","owner_url":"/insider/0001376260","role":"Officer (C.F.O. and C.B.O)","role_mark":"O","role_mark_label":"Officer (C.F.O. and C.B.O)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"C.F.O. and C.B.O.","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":7.66,"price_display":"7.66","price_state":"stated","total_value":114900.0,"total_display":"114,900.00","total_whole":"114,900","shares_owned_after":31151.0,"shares_owned_after_display":"31,151","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-01","filed_date":"2012-02-03","scope":"insider"},{"id":9115065,"accession":"0001209191-11-054602","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-054602","line_url":"/filing/0001209191-11-054602#line-1","is_derivative":false,"issuer_cik":"0001316175","issuer_name":"Anthera Pharmaceuticals Inc","issuer_ticker":"ANTH","issuer_name_source":null,"issuer_url":"/issuer/0001316175","owner_cik":"0001376260","owner_name":"LOWE CHRISTOPHER P.","owner_display_name":"LOWE CHRISTOPHER P.","owner_url":"/insider/0001376260","role":"Officer (Chief Financial Officer & CBO)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer & CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":6.8824,"price_display":"6.88","price_state":"stated","total_value":103236.0,"total_display":"103,236.00","total_whole":"103,236","shares_owned_after":46151.0,"shares_owned_after_display":"46,151","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-11-03","filed_date":"2011-11-04","scope":"insider"},{"id":9144321,"accession":"0001209191-11-053034","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-053034","line_url":"/filing/0001209191-11-053034#line-1","is_derivative":false,"issuer_cik":"0001316175","issuer_name":"Anthera Pharmaceuticals Inc","issuer_ticker":"ANTH","issuer_name_source":null,"issuer_url":"/issuer/0001316175","owner_cik":"0001376260","owner_name":"LOWE CHRISTOPHER P.","owner_display_name":"LOWE CHRISTOPHER P.","owner_url":"/insider/0001376260","role":"Officer (Chief Financial Officer & CBO)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer & CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4637.0,"shares_display":"4,637","price_per_share":7.07,"price_display":"7.07","price_state":"stated","total_value":32783.59,"total_display":"32,783.59","total_whole":"32,784","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-10-25","filed_date":"2011-10-27","scope":"insider"},{"id":9193277,"accession":"0001209191-11-042547","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-11-042547","line_url":"/filing/0001209191-11-042547#line-3","is_derivative":false,"issuer_cik":"0001316175","issuer_name":"Anthera Pharmaceuticals Inc","issuer_ticker":"ANTH","issuer_name_source":null,"issuer_url":"/issuer/0001316175","owner_cik":"0001376260","owner_name":"LOWE CHRISTOPHER P.","owner_display_name":"LOWE CHRISTOPHER P.","owner_url":"/insider/0001376260","role":"Officer (Chief Financial Officer & CBO)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer & CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14600.0,"shares_display":"14,600","price_per_share":6.8789,"price_display":"6.88","price_state":"stated","total_value":100431.94,"total_display":"100,431.94","total_whole":"100,432","shares_owned_after":51151.0,"shares_owned_after_display":"51,151","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-03","filed_date":"2011-08-04","scope":"insider"},{"id":9193276,"accession":"0001209191-11-042547","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-11-042547","line_url":"/filing/0001209191-11-042547","is_derivative":false,"issuer_cik":"0001316175","issuer_name":"Anthera Pharmaceuticals Inc","issuer_ticker":"ANTH","issuer_name_source":null,"issuer_url":"/issuer/0001316175","owner_cik":"0001376260","owner_name":"LOWE CHRISTOPHER P.","owner_display_name":"LOWE CHRISTOPHER P.","owner_url":"/insider/0001376260","role":"Officer (Chief Financial Officer & CBO)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer & CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":7.31429,"price_display":"7.31","price_state":"stated","total_value":36571.45,"total_display":"36,571.45","total_whole":"36,571","shares_owned_after":4937.0,"shares_owned_after_display":"4,937","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-08-02","filed_date":"2011-08-04","scope":"insider","n_lines":2},{"id":9173983,"accession":"0001209191-11-009468","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-009468","line_url":"/filing/0001209191-11-009468#line-1","is_derivative":false,"issuer_cik":"0001316175","issuer_name":"Anthera Pharmaceuticals Inc","issuer_ticker":"ANTH","issuer_name_source":null,"issuer_url":"/issuer/0001316175","owner_cik":"0001376260","owner_name":"LOWE CHRISTOPHER P.","owner_display_name":"LOWE CHRISTOPHER P.","owner_url":"/insider/0001376260","role":"Officer (VP of Administration and CBO)","role_mark":"O","role_mark_label":"Officer (VP of Administration and CBO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Administration and CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80997.0,"shares_display":"80,997","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-02-11","filed_date":"2011-02-14","scope":"insider"},{"id":7630622,"accession":"0001209191-10-047488","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-10-047488","line_url":"/filing/0001209191-10-047488#line-1","is_derivative":false,"issuer_cik":"0001316175","issuer_name":"Anthera Pharmaceuticals Inc","issuer_ticker":"ANTH","issuer_name_source":null,"issuer_url":"/issuer/0001316175","owner_cik":"0001376260","owner_name":"LOWE CHRISTOPHER P.","owner_display_name":"LOWE CHRISTOPHER P.","owner_url":"/insider/0001376260","role":"Officer (CFO & VP of Administration)","role_mark":"O","role_mark_label":"Officer (CFO & VP of Administration)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO & VP of Administration","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":4.18,"price_display":"4.18","price_state":"stated","total_value":20900.0,"total_display":"20,900.00","total_whole":"20,900","shares_owned_after":62523.0,"shares_owned_after_display":"62,523","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-09-24","filed_date":"2010-09-24","scope":"insider"},{"id":7365629,"accession":"0001181431-10-023727","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-10-023727","line_url":"/filing/0001181431-10-023727#line-1","is_derivative":false,"issuer_cik":"0001276591","issuer_name":"HANSEN MEDICAL INC","issuer_ticker":"HNSN","issuer_name_source":null,"issuer_url":"/issuer/0001276591","owner_cik":"0001376260","owner_name":"LOWE CHRISTOPHER P.","owner_display_name":"LOWE CHRISTOPHER P.","owner_url":"/insider/0001376260","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":2.66,"price_display":"2.66","price_state":"stated","total_value":26600.0,"total_display":"26,600.00","total_whole":"26,600","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-04-30","filed_date":"2010-04-30","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":25,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":8,"open_market":true},{"code":"S","label":"Open-market sale","n":17,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":25},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001796129","name":"Vincerx Pharma, Inc.","url":"/issuer/0001796129","role":"Director","n_filings":2,"first_seen":"2021-06-30","last_seen":"2022-08-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001662774","name":"Cortexyme, Inc.","url":"/issuer/0001662774","role":"Officer (COO & Chief Financial Officer)","n_filings":3,"first_seen":"2021-06-30","last_seen":"2021-10-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001276591","name":"HANSEN MEDICAL INC","url":"/issuer/0001276591","role":"Director, Officer (Interim CEO)","n_filings":3,"first_seen":"2010-04-30","last_seen":"2014-05-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001316175","name":"Anthera Pharmaceuticals Inc","url":"/issuer/0001316175","role":"Officer (C.F.O. and C.B.O)","n_filings":6,"first_seen":"2010-09-24","last_seen":"2012-02-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001376260","retrieved_at":"2026-08-27T04:58:16+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}